Arvinas, Inc. ARVN
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- -45.53%
- 1 year
- -41.38%
Held by funds
102 US ETFs and mutual funds hold ARVN · largest positions
- VSEQX 0.11% of fund $13.23M
- VTI 0.00% of fund $11.90M
- IWM 0.01% of fund $10.51M
- NJM 0.01% of fund $10.05M
- VEXRX 0.03% of fund $6.93M
- FSSNX 0.02% of fund $6.01M
- VXF 0.01% of fund $5.47M
- BDSKX 0.09% of fund $5.00M
- VSTCX 0.14% of fund $4.43M
- XPH 0.69% of fund $3.56M
- IWN 0.02% of fund $3.31M
- FESM 0.05% of fund $3.29M
- NAJ 0.02% of fund $3.29M
- IBB 0.03% of fund $3.10M
- VTWO 0.02% of fund $2.75M
- FSMAX 0.01% of fund $2.29M
- SCHA 0.01% of fund $2.10M
- VMNFX 0.34% of fund $2.03M
- DFAS 0.00% of fund $1.51M
- IHE 0.08% of fund $1.43M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 10.27% | 7,062,561 | 58.62M | Dec 30, 2024 |
| EcoR1 Capital, LLC | 9.78% | 6,726,491 | 55.83M | Dec 30, 2024 |
| Blackrock Inc. | 9.55% | 6,566,145 | 54.50M | Dec 30, 2024 |
| Price (T.Rowe) Associates Inc | 5.97% | 4,103,011 | 34.05M | Dec 30, 2024 |
| Pfizer Inc | 5.03% | 3,457,815 | 28.70M | Dec 30, 2024 |
| RTW Investments LP | 4.85% | 3,334,308 | 27.67M | Dec 30, 2024 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Price (T.Rowe) New Horizons Fund | 2.93% | 2,016,090 | 16.73M | Dec 30, 2024 |
| Vanguard Total Stock Market Index Fund | 2.77% | 1,906,825 | 15.83M | Dec 30, 2024 |
| iShares Russell 2000 ETF | 2.53% | 1,737,220 | 14.42M | Dec 30, 2024 |
| Vanguard Small-Cap Index Fund | 2.29% | 1,575,209 | 13.07M | Dec 30, 2024 |
| Vanguard Extended Market Index Fund | 1.40% | 962,734 | 7.99M | Dec 30, 2024 |
| Vanguard Explorer Fund, Inc. | 1.36% | 933,244 | 7.75M | Oct 30, 2024 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs ARVN, and what each was last paid
Randy Teel, CEO, President & DirectorAverage age 54
| Name | Title | Pay | Age |
|---|---|---|---|
| Randy Teel | CEO, President & Director | $711K | 46 |
| Andrew Saik | Chief Financial Officer & Treasurer | $820K | 57 |
| Angela Cacace | Chief Scientific Officer | $758K | 58 |
| David Loomis | Vice President & Chief Accounting Officer | — | 52 |
| Jared Freedberg | General Counsel & Corporate Secretary | — | 57 |
| Jeff Boyle | Vice President of Investor Relations | — | — |
| Steve Weiss | Senior Vice President & Chief Human Resources Officer | — | 56 |
| Kelly Page | Senior Vice President & Global Head of Oncology Strategy and Program Leadership | — | — |
| Paul McInulty | Senior Vice President of Regulatory Affairs | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAIN LINDA C | Director | Stock Award(Grant) | May 28, 2024 | 10,020 |
| BERKOWITZ NOAH | Officer | Stock Award(Grant) | Feb 12, 2025 | 118,681 |
| CACACE ANGELA M | Officer | Sale | Feb 23, 2025 | 97,231 |
| CUNNINGHAM EVERETT V | Director | Stock Award(Grant) | May 28, 2024 | 10,020 |
| HOUSTON JOHN G | Chief Executive Officer | Sale | Feb 23, 2025 | 1,157,480 |
| LOOMIS DAVID K | Officer | Sale | Feb 23, 2025 | 18,863 |
